CN Bio logoCN Bio logoCN Bio logoCN Bio logo
  • Products
    • Explore our solutions


      PhysioMimix™ products enable you to recreate complex human biology and accurately predict human drug responses

      PhysioMimix OOC

      PhysioMimix OOC systems
      Learn more

      Consumables

      • Multi-chip plates
      • 3D validated cells
      • NASH-in-a-box
      Learn more

      Models

      • Single-organ models
      • Multi-organ models

      Support packages

      • PhysioMimix™ support packages
  • Applications
    • Discover the applications


      Investigate the application areas that our PhysioMimix™ products and services support

      Learn more

      Disease modeling

      • Non-Alcoholic Steatohepatitis
      • Hepatitis B
      • Oncology
      • COVID-19
      Learn more

      Safety toxicology

      • Drug-induced liver injury
      • Immune-mediated toxicities
      Learn more

      ADME

      • Drug absorption
      • Drug metabolism
      • Drug bioavailability
      Learn more
  • Services
    • Studies as a service


      Our team will work collaboratively with you to design a study around your research goals and generate actionable data within weeks

      Learn more
      NAFLD / NASH icons

      NAFLD / NASH

      Drug-induced liver injury icon

      Drug-induced liver injury

      icon adme |

      ADME

      Oncology icon

      Oncology

  • Resources
  • Company
    • About us


      Meet the team, explore our culture and discover what to expect when working with us

      CN Bio team photo
      About us

      Latest news

      • The FDA further expands collaboration with CN Bio to evaluate the PhysioMimix Multi-organ microphysiological system

      • The U.S. FDA Modernization Act 2.0. Now the animal testing mandate is removed, learn what can be embraced in its place.

      • CN Bio appoints Dr Paul Brooks as Chief Executive Officer

      View all news

      Upcoming Events

      • SLAS2023

      • SOT 2023

      • WORD 2023

      • SLAS Europe 2023

      • MPS World Summit 2023

      View all events

      Join the team!

      View all jobs
  • Contact
  • Products
    • PhysioMimix™ OOC Microphysiological Systems
    • Consumables
      • PhysioMimix™ multi-chip plates
      • 3D validated cells
      • NASH-in-a-box
    • Organ-on-a-chip models
    • Support packages
  • Applications
    • Disease modeling
    • Safety toxicology
    • ADME
  • Services
    • Non-Alcoholic Steatohepatitis
    • Drug-Induced Liver Injury
    • ADME
  • Resources
  • Company
    • About us
    • Events
    • News
    • Careers
  • Contact
  • Skip to main content
  • Skip to footer
Chat live with an expert

Media Coverage

May 1, 2018

Radio 4’s PM features CN Bio Human Organ-on-Chips

Listen to Radio 4’s flagship PM programme with Caroline Quinn interview CN Bio Innovations’ CEO Dr Emma Sceats. Emma describes London-based CN Bio’s

Category iconMedia Coverage

February 15, 2018

Hepatitis B research using CN Bio Organ-on-Chips published in Nature Communications

London, UK, February 15 2018: In an article published in Nature Communications scientists at Imperial College London have demonstrated how pathogens

Category iconMedia Coverage

February 3, 2017

Huffington Post features CN Bio

Huffington Post features CN Bio CEO: Women in Innovation: Developing 'Organs-on-Chips' Interview clip: "My background as a chemist means that I like

Category iconMedia Coverage

November 30, 2016

CN Bio featured on the Discovery Channel

[et_pb_section fb_built="1" admin_label="section" _builder_version="3.22"][et_pb_row admin_label="row" _builder_version="3.25"

Category iconMedia Coverage Tag iconDiscovery Channel,  media,  organ-on-chip

August 14, 2015

Al Jazeera

CN Bio Innovations features in Al Jazeera documentary “The Cure” http://www.aljazeera.com/programmes/thecure/2015/08/liver-chip-150810124609243.html

Category iconMedia Coverage

June 24, 2015

BBC World Service

[et_pb_section fb_built="1" admin_label="section" _builder_version="3.22" custom_padding="0px|||||"][et_pb_row admin_label="row"

Category iconMedia Coverage

June 13, 2015

The Economist

Towards a body on a

Category iconMedia Coverage

April 29, 2015

Bloomberg

Drug Testing, Now without the Chimp: http://www.bloomberg.com/news/articles/2015-04-29/chimps-give-way-to-chips-as-drug-makers-seek-lower-costs

Category iconMedia Coverage

April 29, 2015

Bloomberg

Drug Disruption: The ‘Liver-on-a-chip’: http://www.bloomberg.com/news/videos/2015-04-29/drug-disruption-the-liver-on-a-chip-

Category iconMedia Coverage

Speak to our experts

Speak directly with one of our OOC experts to see how our products and services can support your studies

Request a meeting

Footer

CN Bio logo

332 Cambridge Science Park, Milton Road
Cambridge, CB4 0WN

+44 (0) 1223 737941

Privacy | Cookies | Terms | Regulatory | Accessibility

©2023 CN Bio Innovations Ltd
Registered No. ‍06517359. VAT No. 978184563

Latest news

  • The FDA further expands collaboration with CN Bio to evaluate the PhysioMimix Multi-organ microphysiological system January 17, 2023
  • The U.S. FDA Modernization Act 2.0. Now the animal testing mandate is removed, learn what can be embraced in its place. January 9, 2023
  • CN Bio appoints Dr Paul Brooks as Chief Executive Officer December 19, 2022

Upcoming events

MPS World Summit 2023 June 26-30, 2023

SLAS Europe 2023 May 22-26, 2023

SLAS2023 February 25 - March 1, 2023